Image_1_Long Non-coding RNA MEG3 Promotes Pyroptosis in Testicular Ischemia-Reperfusion Injury by Targeting MiR-29a to Modulate PTEN Expression.TIF
Increasing evidence shows that the abnormal long non-coding RNAs (lncRNAs) expression is closely related to ischemia-reperfusion injury (I/R) progression. Studies have previously described that lncRNA MEG3 regulates pyroptosis in various organs I/R. Nevertheless, the related mechanisms of MEG3 in testicular I/R has not been clarified. The aim of this research is to unravel underlying mechanisms of the regulation of pyroptosis mediated by MEG3 during testicular I/R. We have established a testicular torsion/detorsion (T/D) model and an oxygen-glucose deprivation/reperfusion (OGD/R)-treated spermatogenic cell model. Testicular ischemic injury was assessed by H&E staining. Western blotting, quantitative real-time PCR, MDA, and SOD tests and immunohistochemistry measured the expression of MEG3 and related proteins and the level of ROS production in testicular tissues. Quantitative real-time PCR and western blotting determined the relative expression of MEG3, miR-29a, and relevant proteins in GC-1. Cell viability and cytotoxicity were measured by CCK-8 and LDH assays. Secretion and expression levels of inflammatory proteins were determined by ELISA, immunofluorescence and western blotting. The interaction among MEG3, miR-29a, and PTEN was validated through a dual luciferase reporter assay and Ago2-RIP. In this research, we identified that MEG3 was upregulated in animal specimens and GC-1. In loss of function or gain of function assays, we verified that MEG3 could promote pyroptosis. Furthermore, we found that MEG3 negatively regulated miR-29a expression at the posttranscriptional level and promoted PTEN expression, and further promoted pyroptosis. Therefore, we explored the interaction among MEG3, miR-29a and PTEN and found that MEG3 directly targeted miR-29a, and miR-29a targeted PTEN. Overexpression of miR-29a effectively eliminated the upregulation of PTEN induced by MEG3, indicating that MEG3 regulates PTEN expression by targeting miR-29a. In summary, our research indicates that MEG3 contributes to pyroptosis by regulating miR-29a and PTEN during testicular I/R, indicating that MEG3 may be a potential therapeutic target in testicular torsion.
History
References
- https://doi.org//10.1016/j.bbrc.2010.04.012
- https://doi.org//10.1038/s41419-018-0282-x
- https://doi.org//10.1002/ijc.26052
- https://doi.org//10.1016/s0022-5347%2817%2952758-5
- https://doi.org//10.1158/1078-0432.Ccr-18-1656
- https://doi.org//10.1016/j.ymthe.2018.12.015
- https://doi.org//10.1002/jcb.27651
- https://doi.org//10.1038/emm.2017.278
- https://doi.org//10.1007/s00424-018-2213-1
- https://doi.org//10.1124/jpet.119.256982
- https://doi.org//10.1007/s12011-019-01865-6
- https://doi.org//10.1016/j.neuroscience.2020.04.020
- https://doi.org//10.1016/j.biopha.2019.109129
- https://doi.org//10.1097/00005392-199809020-00053
- https://doi.org//10.1016/j.intimp.2019.01.002
- https://doi.org//10.1002/jcb.26286
- https://doi.org//10.3389/fgene.2014.00008
- https://doi.org//10.1159/000488738
- https://doi.org//10.1016/j.expneurol.2019.113139
- https://doi.org//10.1016/j.biopha.2020.110778
- https://doi.org//10.1242/jcs.207365
- https://doi.org//10.1001/archpedi.159.12.1167
- https://doi.org//10.1016/j.urology.2014.07.022
- https://doi.org//10.1124/jpet.115.226936
- https://doi.org//10.1002/jcb.27604
- https://doi.org//10.3389/fphys.2017.00966
- https://doi.org//10.3389/fnmol.2018.00096
- https://doi.org//10.1093/nar/gky1190
- https://doi.org//10.1016/j.biocel.2008.09.022
- https://doi.org//10.1097/01.ju.0000144203.30718.19
- https://doi.org//10.1111/and.13134
- https://doi.org//10.1038/ncomms4596
- https://doi.org//10.1159/000492979
- https://doi.org//10.3389/fphys.2020.00906
- https://doi.org//10.1038/s41419-017-0047-y
- https://doi.org//10.2147/dddt.S195412
- https://doi.org//10.1016/j.celrep.2012.06.003
- https://doi.org//10.1111/jpi.12449
- https://doi.org//10.1080/0886022x.2020.1818579
- https://doi.org//10.1042/bsr20190210